DK2094331T3 - Indretninger og opløsninger til afgivelse af aktivstoffer til målsteder - Google Patents
Indretninger og opløsninger til afgivelse af aktivstoffer til målsteder Download PDFInfo
- Publication number
- DK2094331T3 DK2094331T3 DK07865883.8T DK07865883T DK2094331T3 DK 2094331 T3 DK2094331 T3 DK 2094331T3 DK 07865883 T DK07865883 T DK 07865883T DK 2094331 T3 DK2094331 T3 DK 2094331T3
- Authority
- DK
- Denmark
- Prior art keywords
- wound
- solution
- rinse solution
- use according
- irrigation
- Prior art date
Links
- 239000013543 active substance Substances 0.000 title claims description 24
- 208000027418 Wounds and injury Diseases 0.000 claims description 117
- 206010052428 Wound Diseases 0.000 claims description 112
- 239000000243 solution Substances 0.000 claims description 52
- 239000000463 material Substances 0.000 claims description 19
- 229960003333 chlorhexidine gluconate Drugs 0.000 claims description 11
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 239000000356 contaminant Substances 0.000 claims description 9
- 238000011010 flushing procedure Methods 0.000 claims description 9
- 239000008223 sterile water Substances 0.000 claims description 4
- 239000012487 rinsing solution Substances 0.000 claims 2
- 229940088623 biologically active substance Drugs 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
- 230000002262 irrigation Effects 0.000 description 39
- 238000003973 irrigation Methods 0.000 description 39
- 238000000034 method Methods 0.000 description 34
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 25
- 229960003260 chlorhexidine Drugs 0.000 description 25
- 241000894006 Bacteria Species 0.000 description 22
- 229940113601 irrigation solution Drugs 0.000 description 21
- 208000015181 infectious disease Diseases 0.000 description 19
- 239000003814 drug Substances 0.000 description 15
- 239000003795 chemical substances by application Substances 0.000 description 14
- 239000012530 fluid Substances 0.000 description 13
- 229940079593 drug Drugs 0.000 description 11
- 210000001519 tissue Anatomy 0.000 description 11
- 238000012377 drug delivery Methods 0.000 description 9
- 208000037942 Methicillin-resistant Staphylococcus aureus infection Diseases 0.000 description 8
- 239000004480 active ingredient Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 108700042778 Antimicrobial Peptides Proteins 0.000 description 7
- 102000044503 Antimicrobial Peptides Human genes 0.000 description 7
- 208000034693 Laceration Diseases 0.000 description 7
- 239000003242 anti bacterial agent Substances 0.000 description 7
- 229940088710 antibiotic agent Drugs 0.000 description 7
- 230000006378 damage Effects 0.000 description 7
- 229940124645 emergency medicine Drugs 0.000 description 7
- 208000014674 injury Diseases 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 241000700605 Viruses Species 0.000 description 6
- 230000002421 anti-septic effect Effects 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 238000007726 management method Methods 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 5
- 206010041925 Staphylococcal infections Diseases 0.000 description 5
- 238000011109 contamination Methods 0.000 description 5
- 230000035876 healing Effects 0.000 description 5
- 208000015688 methicillin-resistant staphylococcus aureus infectious disease Diseases 0.000 description 5
- 238000005299 abrasion Methods 0.000 description 4
- 230000000845 anti-microbial effect Effects 0.000 description 4
- 239000000032 diagnostic agent Substances 0.000 description 4
- 229940039227 diagnostic agent Drugs 0.000 description 4
- 239000000820 nonprescription drug Substances 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 230000000699 topical effect Effects 0.000 description 4
- 241000233866 Fungi Species 0.000 description 3
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 229940064004 antiseptic throat preparations Drugs 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 229940064804 betadine Drugs 0.000 description 3
- 238000007906 compression Methods 0.000 description 3
- 230000006835 compression Effects 0.000 description 3
- 239000003599 detergent Substances 0.000 description 3
- 239000003193 general anesthetic agent Substances 0.000 description 3
- 210000000987 immune system Anatomy 0.000 description 3
- 230000002147 killing effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229960003085 meticillin Drugs 0.000 description 3
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 210000004872 soft tissue Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 229940124597 therapeutic agent Drugs 0.000 description 3
- 241000701022 Cytomegalovirus Species 0.000 description 2
- 241000725303 Human immunodeficiency virus Species 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 244000285963 Kluyveromyces fragilis Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 229920000153 Povidone-iodine Polymers 0.000 description 2
- 206010072170 Skin wound Diseases 0.000 description 2
- 241000295644 Staphylococcaceae Species 0.000 description 2
- 241000193996 Streptococcus pyogenes Species 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 108010059993 Vancomycin Proteins 0.000 description 2
- 241000700647 Variola virus Species 0.000 description 2
- 241001148470 aerobic bacillus Species 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 239000003443 antiviral agent Substances 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 239000003855 balanced salt solution Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- XIWFQDBQMCDYJT-UHFFFAOYSA-M benzyl-dimethyl-tridecylazanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 XIWFQDBQMCDYJT-UHFFFAOYSA-M 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000012829 chemotherapy agent Substances 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000008260 defense mechanism Effects 0.000 description 2
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000000417 fungicide Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 239000003061 homeopathic agent Substances 0.000 description 2
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 2
- 239000003589 local anesthetic agent Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000002324 mouth wash Substances 0.000 description 2
- 229960001019 oxacillin Drugs 0.000 description 2
- UWYHMGVUTGAWSP-JKIFEVAISA-N oxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=CC=CC=C1 UWYHMGVUTGAWSP-JKIFEVAISA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000003239 periodontal effect Effects 0.000 description 2
- 229920001993 poloxamer 188 Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 229960001621 povidone-iodine Drugs 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 239000003380 propellant Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 2
- 229960003165 vancomycin Drugs 0.000 description 2
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 2
- MYPYJXKWCTUITO-LYRMYLQWSA-O vancomycin(1+) Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C([O-])=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)[NH2+]C)[C@H]1C[C@](C)([NH3+])[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-O 0.000 description 2
- 208000030507 AIDS Diseases 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 241000606125 Bacteroides Species 0.000 description 1
- 244000197813 Camelina sativa Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 241000144583 Candida dubliniensis Species 0.000 description 1
- 241000222173 Candida parapsilosis Species 0.000 description 1
- 241000222178 Candida tropicalis Species 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 102000019034 Chemokines Human genes 0.000 description 1
- 108010012236 Chemokines Proteins 0.000 description 1
- 241000606153 Chlamydia trachomatis Species 0.000 description 1
- 241001508813 Clavispora lusitaniae Species 0.000 description 1
- 241000193163 Clostridioides difficile Species 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- 102000000541 Defensins Human genes 0.000 description 1
- 108010002069 Defensins Proteins 0.000 description 1
- 206010061619 Deformity Diseases 0.000 description 1
- 208000002064 Dental Plaque Diseases 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- 241000194031 Enterococcus faecium Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241001480036 Epidermophyton floccosum Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- CTKXFMQHOOWWEB-UHFFFAOYSA-N Ethylene oxide/propylene oxide copolymer Chemical compound CCCOC(C)COCCO CTKXFMQHOOWWEB-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 241000588915 Klebsiella aerogenes Species 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000893980 Microsporum canis Species 0.000 description 1
- 208000025370 Middle East respiratory syndrome Diseases 0.000 description 1
- 241000893976 Nannizzia gypsea Species 0.000 description 1
- 108090000189 Neuropeptides Proteins 0.000 description 1
- 208000002606 Paramyxoviridae Infections Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 241000235645 Pichia kudriavzevii Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000183024 Populus tremula Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000186429 Propionibacterium Species 0.000 description 1
- 241000605036 Selenomonas Species 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- 206010062255 Soft tissue infection Diseases 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 241000192087 Staphylococcus hominis Species 0.000 description 1
- 241000191978 Staphylococcus simulans Species 0.000 description 1
- 241000194019 Streptococcus mutans Species 0.000 description 1
- 241000194024 Streptococcus salivarius Species 0.000 description 1
- 241000194023 Streptococcus sanguinis Species 0.000 description 1
- 241001045770 Trichophyton mentagrophytes Species 0.000 description 1
- 241001148134 Veillonella Species 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- 241000222126 [Candida] glabrata Species 0.000 description 1
- 238000012084 abdominal surgery Methods 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004721 adaptive immunity Effects 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 150000001449 anionic compounds Chemical class 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940019748 antifibrinolytic proteinase inhibitors Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000000386 athletic effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 102000014509 cathelicidin Human genes 0.000 description 1
- 108060001132 cathelicidin Proteins 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 229960002798 cetrimide Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940038705 chlamydia trachomatis Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000001841 cholesterols Chemical class 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 238000001804 debridement Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000014670 detection of bacterium Effects 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- -1 entsulfon Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000000887 face Anatomy 0.000 description 1
- 238000005429 filling process Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229940005494 general anesthetics Drugs 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 239000002874 hemostatic agent Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000015788 innate immune response Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002991 molded plastic Substances 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 230000006461 physiological response Effects 0.000 description 1
- 229940095608 physiosol Drugs 0.000 description 1
- 229940044519 poloxamer 188 Drugs 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 231100000683 possible toxicity Toxicity 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229940096992 potassium oleate Drugs 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 229940035294 tis-u-sol Drugs 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 229940032912 zephiran Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M3/00—Medical syringes, e.g. enemata; Irrigators
- A61M3/02—Enemata; Irrigators
- A61M3/0233—Enemata; Irrigators characterised by liquid supply means, e.g. from pressurised reservoirs
- A61M3/0254—Enemata; Irrigators characterised by liquid supply means, e.g. from pressurised reservoirs the liquid being pumped
- A61M3/0262—Enemata; Irrigators characterised by liquid supply means, e.g. from pressurised reservoirs the liquid being pumped manually, e.g. by squeezing a bulb
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M3/00—Medical syringes, e.g. enemata; Irrigators
- A61M3/02—Enemata; Irrigators
- A61M3/0279—Cannula; Nozzles; Tips; their connection means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M35/00—Devices for applying media, e.g. remedies, on the human body
- A61M35/003—Portable hand-held applicators having means for dispensing or spreading integral media
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M3/00—Medical syringes, e.g. enemata; Irrigators
- A61M3/02—Enemata; Irrigators
- A61M3/0279—Cannula; Nozzles; Tips; their connection means
- A61M3/0287—Cannula; Nozzles; Tips; their connection means with an external liquid collector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Devices For Medical Bathing And Washing (AREA)
- Surgical Instruments (AREA)
- Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Cosmetics (AREA)
Claims (15)
1. Sårskylningsanordning omfattende et reservoir/beholderhus (60), indeholdende en steril sårskylleopløsning, hvor sårskylningsanordningen omfatter et udledningsorgan der leder en tryksat strøm af sårskylleopløsningen når beholderhuset er tryksat, hvor beholderhuset er fremstillet af et elastisk sammentrykkeligt materiale og hvor udledningsorganet omfatter en flerhed af porte (96) gennem hvilken den sterile sårskylleopløsning passerer når beholderhuset er sammentrykt, kendetegnet ved at sårskylleopløsningen omfatter sterilt vand med chlorhexidingluconat deri ved en koncentration på mindre end 1%.
2. Sårskylleanordning, ifølge krav 1, der indeholder fra 250 ml til 750 ml sårskylleopløsning.
3. Sårskylleanordning, ifølge krav 1, hvor hver af portene/gennemløbene har en diameter på fra ca. en 10 gauge- til en 25 gauge nål.
4. Anordningen, ifølge krav 1, har porte/gennemløb der omfatter formede dyser hvor indløbet til dysen er rundet og er større end udløbet.
5. Sårskylleopløsning af sterilt vand og chlorhexidingluconat ved en koncentration på mindre end 1% til anvendelse i behandling af sår, hvor sårskylleopløsningen udledes fra sårskylningsanordningen ifølge krav 1, fra beholderhuset og gennem portene til at frembringe en dispergeret strøm af sårskylleopløsningen rettet mod såret, hvor den dispergerede strøm påføres med tilstrækkelig kraft til at fjerne forureninger, derved effektivt skylle såret.
6. Sårskylleopløsning, til anvendelse ifølge krav 5, hvor sårskylleopløsningen udledes fra portene ved et tryk mellem ca. 4 PSI (0,276 bar) og ca. 20 PSI (1,379 bar).
7. Sårskylleopløsning, til anvendelse ifølge krav 5, hvor fra 250 ml til 750 ml sårskylleopløsning påføres til såret.
8. Sårskylleopløsning, til anvendelse ifølge krav 5, eller anordningen ifølge krav 1, hvor anordningen yderligere omfatter en retursprøjteskærm.
9. Sårskylleopløsning, til anvendelse ifølge krav 5, yderligere omfattende skylning af såret indenfor 5 minutter med sårskylleanordning der ikke indeholder chlorhexidingluconat.
10. Sårskylleopløsning, til anvendelse ifølge krav 5, anvendes til at behandle et sår i huden på et menneske.
11. Sårskylleopløsning, til anvendelse ifølge krav 5, eller anordningen ifølge krav 1, hvor det biologiske aktive stof er chlorhexidingluconat ved en koncentration på 0. 05% eller derunder.
12. Sårskylleopløsning, til anvendelse ifølge krav 5, eller anordningen ifølge krav 1, endvidere omfattende yderligere biologiske aktive stoffer.
13. Sårskylleopløsning, til anvendelse ifølge krav 5, eller anordningen ifølge krav 1, hvor skylleopløsningens pH er mellem pH 5,5 og pH 7,0.
14. Sårskylleopløsning, til anvendelse ifølge krav 5, har porte/gennemløb der omfatter formede dyser hvor indløbet til dysen er rundet og er større end udløbet.
15. Sårskylningsanordning ifølge krav 1, hvor sårskylleopløsningen omfatter sterilt vand med chlorhexidingluconat deri ved en koncentration på 0,05% eller derunder.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87578806P | 2006-12-19 | 2006-12-19 | |
| PCT/US2007/088185 WO2008077114A2 (en) | 2006-12-19 | 2007-12-19 | Devices and methods for delivering active agents to target sites |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2094331T3 true DK2094331T3 (da) | 2016-12-05 |
Family
ID=42113790
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK07865883.8T DK2094331T3 (da) | 2006-12-19 | 2007-12-19 | Indretninger og opløsninger til afgivelse af aktivstoffer til målsteder |
Country Status (20)
| Country | Link |
|---|---|
| EP (2) | EP2094331B1 (da) |
| JP (1) | JP2010512980A (da) |
| KR (1) | KR101482241B1 (da) |
| CN (2) | CN101594895B (da) |
| AU (1) | AU2007333678B2 (da) |
| BR (1) | BRPI0721044B8 (da) |
| CA (1) | CA2669958C (da) |
| DK (1) | DK2094331T3 (da) |
| ES (1) | ES2600302T3 (da) |
| HU (1) | HUE031475T2 (da) |
| IL (1) | IL198769A (da) |
| LT (1) | LT2094331T (da) |
| MX (2) | MX2009006719A (da) |
| NZ (1) | NZ577695A (da) |
| PL (1) | PL2094331T3 (da) |
| PT (1) | PT2094331T (da) |
| RU (1) | RU2009127700A (da) |
| SI (1) | SI2094331T1 (da) |
| WO (1) | WO2008077114A2 (da) |
| ZA (1) | ZA200903298B (da) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2094331B1 (en) * | 2006-12-19 | 2016-09-28 | Innovation Technologies, Inc. | Devices and solutions for delivering active agents to target sites |
| DE202008017185U1 (de) * | 2008-12-30 | 2010-05-12 | Siegfried Generics International Ag | Dosiervorrichtung |
| CA2778081A1 (en) * | 2009-10-26 | 2011-05-12 | Innovation Technologies, Inc. | Devices, methods, and composition for controlling infections |
| CN103619485B (zh) | 2011-05-09 | 2017-08-08 | 英倍尔药业股份有限公司 | 用于鼻腔药物递送的喷嘴 |
| EP2996756B1 (de) * | 2013-05-15 | 2020-12-16 | Solvamed GmbH | Hautapplikator zur applikation von leichtflüchtigen substanzen |
| CN105920693A (zh) * | 2016-05-10 | 2016-09-07 | 安纲 | 一种注射器冲洗针头 |
| CN111617373B (zh) * | 2020-06-29 | 2024-07-12 | 北京大学深圳医院 | 妇科护理装置 |
| CN113925732B (zh) * | 2021-10-13 | 2024-06-11 | 周美丽 | 一种皮肤科用的创面清理装置及方法 |
| KR102942577B1 (ko) | 2023-08-31 | 2026-03-24 | 주식회사 킴코 | 환자의 환부를 세척하기 위한 세척액을 수용하는 수용기구 |
| US20250213542A1 (en) * | 2023-12-29 | 2025-07-03 | IRRIMAX Corporation | Devices and methods for delivering synergistic active agents to target sites |
| US20250213777A1 (en) * | 2023-12-29 | 2025-07-03 | IRRIMAX Corporation | Devices and methods for delivering synergistic active agents to target sites |
| US20250213505A1 (en) * | 2023-12-29 | 2025-07-03 | IRRIMAX Corporation | Devices and methods for delivering synergistic active agents to target sites |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2013636A1 (en) | 1989-04-06 | 1990-10-06 | Sang I. Han | Disposable pressure wound irrigation device |
| US5071104A (en) | 1989-05-16 | 1991-12-10 | Andermac, Inc. | Three-way elastic valve for a wound irrigation apparatus |
| US20010037095A1 (en) * | 1994-06-14 | 2001-11-01 | Rucinski Paul J. | Novel wound irrigation device and method |
| JPH09301858A (ja) * | 1996-05-13 | 1997-11-25 | Senju Pharmaceut Co Ltd | グルコン酸クロルヘキシジン安定化水性薬剤 |
| US6861067B2 (en) * | 1998-09-17 | 2005-03-01 | Sherwood Services Ag | Hydrogel wound dressing and the method of making and using the same |
| DE69825495T2 (de) * | 1998-12-23 | 2005-07-28 | Idea Ag | Verbesserte formulierung zur topischen, nichtinvasiven anwendung in vivo |
| JP2005013309A (ja) * | 2003-06-24 | 2005-01-20 | Meisei Sansho Kk | 消毒剤含浸体 |
| ATE386558T1 (de) * | 2003-09-22 | 2008-03-15 | Innovation Technologies Inc | Wundirrigationsvorrichtung und verfahren |
| WO2007070861A1 (en) * | 2005-12-14 | 2007-06-21 | Binary, Llc | Binary compositions and methods for sterilization |
| EP2094331B1 (en) * | 2006-12-19 | 2016-09-28 | Innovation Technologies, Inc. | Devices and solutions for delivering active agents to target sites |
-
2007
- 2007-12-19 EP EP07865883.8A patent/EP2094331B1/en active Active
- 2007-12-19 JP JP2009543192A patent/JP2010512980A/ja active Pending
- 2007-12-19 CN CN2007800467197A patent/CN101594895B/zh active Active
- 2007-12-19 RU RU2009127700/14A patent/RU2009127700A/ru not_active Application Discontinuation
- 2007-12-19 EP EP16184903.9A patent/EP3117849B1/en active Active
- 2007-12-19 CA CA2669958A patent/CA2669958C/en active Active
- 2007-12-19 DK DK07865883.8T patent/DK2094331T3/da active
- 2007-12-19 MX MX2009006719A patent/MX2009006719A/es active IP Right Grant
- 2007-12-19 CN CN201210232003.9A patent/CN102727954B/zh not_active Expired - Fee Related
- 2007-12-19 LT LTEP07865883.8T patent/LT2094331T/lt unknown
- 2007-12-19 MX MX2014010778A patent/MX352509B/es unknown
- 2007-12-19 PL PL07865883T patent/PL2094331T3/pl unknown
- 2007-12-19 HU HUE07865883A patent/HUE031475T2/en unknown
- 2007-12-19 NZ NZ577695A patent/NZ577695A/en unknown
- 2007-12-19 ES ES07865883.8T patent/ES2600302T3/es active Active
- 2007-12-19 PT PT78658838T patent/PT2094331T/pt unknown
- 2007-12-19 SI SI200731851A patent/SI2094331T1/sl unknown
- 2007-12-19 WO PCT/US2007/088185 patent/WO2008077114A2/en not_active Ceased
- 2007-12-19 AU AU2007333678A patent/AU2007333678B2/en active Active
- 2007-12-19 BR BRPI0721044A patent/BRPI0721044B8/pt active IP Right Grant
- 2007-12-19 KR KR1020097012684A patent/KR101482241B1/ko active Active
-
2009
- 2009-05-13 ZA ZA200903298A patent/ZA200903298B/xx unknown
- 2009-05-14 IL IL198769A patent/IL198769A/en active IP Right Grant
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2094331T3 (da) | Indretninger og opløsninger til afgivelse af aktivstoffer til målsteder | |
| US7662125B2 (en) | Devices and methods for delivering active agents to target sites | |
| AU758441B2 (en) | Novel wound irrigation device and method | |
| WO2011056486A2 (en) | Devices, methods, and composition for controlling infections | |
| WO2025144476A1 (en) | Wound irrigation devices and methods for delivering synergistic active agents | |
| WO2025144477A1 (en) | Wound irrigation devices and methods for delivering synergistic active agents | |
| WO2025144475A1 (en) | Wound irrigation devices and methods for delivering synergistic active agents | |
| HK1138219B (en) | Devices and methods for delivering active agents to target sites | |
| HK1177437B (en) | Devices and methods for delivering active agents to target sites |